ID   DCR1B_HUMAN             Reviewed;         532 AA.
AC   Q9H816; Q9H9E5;
DT   16-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   22-JUL-2015, entry version 115.
DE   RecName: Full=5' exonuclease Apollo;
DE            EC=3.1.-.-;
DE   AltName: Full=DNA cross-link repair 1B protein;
DE   AltName: Full=SNM1 homolog B;
DE            Short=SNMIB;
DE            Short=hSNM1B;
GN   Name=DCLRE1B; Synonyms=SNM1B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Retinoblastoma, and Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS LEU-46; TYR-61 AND
RP   ASN-462.
RG   NIEHS SNPs program;
RL   Submitted (DEC-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=15572677; DOI=10.1128/MCB.24.24.10733-10741.2004;
RA   Ishiai M., Kimura M., Namikoshi K., Yamazoe M., Yamamoto K.,
RA   Arakawa H., Agematsu K., Matsushita N., Takeda S., Buerstedde J.-M.,
RA   Takata M.;
RT   "DNA cross-link repair protein SNM1A interacts with PIAS1 in nuclear
RT   focus formation.";
RL   Mol. Cell. Biol. 24:10733-10741(2004).
RN   [6]
RP   FUNCTION.
RX   PubMed=15467758; DOI=10.1038/sj.onc.1207895;
RA   Demuth I., Digweed M., Concannon P.;
RT   "Human SNM1B is required for normal cellular response to both DNA
RT   interstrand crosslink-inducing agents and ionizing radiation.";
RL   Oncogene 23:8611-8618(2004).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY, FUNCTION, SUBCELLULAR LOCATION,
RP   AND INTERACTION WITH TERF2.
RX   PubMed=16730176; DOI=10.1016/j.cub.2006.05.022;
RA   van Overbeek M., de Lange T.;
RT   "Apollo, an Artemis-related nuclease, interacts with TRF2 and protects
RT   human telomeres in S phase.";
RL   Curr. Biol. 16:1295-1302(2006).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY, FUNCTION, SUBCELLULAR LOCATION,
RP   AND INTERACTION WITH TERF2.
RX   PubMed=16730175; DOI=10.1016/j.cub.2006.05.021;
RA   Lenain C., Bauwens S., Amiard S., Brunori M., Giraud-Panis M.J.,
RA   Gilson E.;
RT   "The Apollo 5' exonuclease functions together with TRF2 to protect
RT   telomeres from DNA repair.";
RL   Curr. Biol. 16:1303-1310(2006).
RN   [9]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH TERF2.
RX   PubMed=16606622; DOI=10.1074/jbc.C600038200;
RA   Freibaum B.D., Counter C.M.;
RT   "hSnm1B is a novel telomere-associated protein.";
RL   J. Biol. Chem. 281:15033-15036(2006).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH TERF2.
RX   PubMed=18468965; DOI=10.1016/j.dnarep.2008.03.020;
RA   Demuth I., Bradshaw P.S., Lindner A., Anders M., Heinrich S.,
RA   Kallenbach J., Schmelz K., Digweed M., Meyn M.S., Concannon P.;
RT   "Endogenous hSNM1B/Apollo interacts with TRF2 and stimulates ATM in
RT   response to ionizing radiation.";
RL   DNA Repair 7:1192-1201(2008).
RN   [11]
RP   UBIQUITINATION, AND INTERACTION WITH TERF2.
RX   PubMed=18593705; DOI=10.1074/jbc.M800388200;
RA   Freibaum B.D., Counter C.M.;
RT   "The protein hSnm1B is stabilized when bound to the telomere-binding
RT   protein TRF2.";
RL   J. Biol. Chem. 283:23671-23676(2008).
RN   [12]
RP   FUNCTION, AND INTERACTION WITH MUS81; MRE11 AND FANCD2.
RX   PubMed=18469862; DOI=10.1038/onc.2008.139;
RA   Bae J.B., Mukhopadhyay S.S., Liu L., Zhang N., Tan J., Akhter S.,
RA   Liu X., Shen X., Li L., Legerski R.J.;
RT   "Snm1B/Apollo mediates replication fork collapse and S Phase
RT   checkpoint activation in response to DNA interstrand cross-links.";
RL   Oncogene 27:5045-5056(2008).
RN   [13]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH SPAG5, AND
RP   MUTAGENESIS OF ASP-14 AND HIS-276.
RX   PubMed=19197158;
RA   Liu L., Akhter S., Bae J.B., Mukhopadhyay S.S., Richie C.T., Liu X.,
RA   Legerski R.;
RT   "SNM1B/Apollo interacts with astrin and is required for the prophase
RT   cell cycle checkpoint.";
RL   Cell Cycle 8:628-638(2009).
RN   [14]
RP   FUNCTION, AND INTERACTION WITH HSPA2; HSPA8 AND HSPA14.
RX   PubMed=19411856;
RA   Anders M., Mattow J., Digweed M., Demuth I.;
RT   "Evidence for hSNM1B/Apollo functioning in the HSP70 mediated DNA
RT   damage response.";
RL   Cell Cycle 8:1725-1732(2009).
RN   [15]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH TERF2, AND
RP   MUTAGENESIS OF ASP-14; HIS-33 AND ASP-35.
RX   PubMed=20655466; DOI=10.1016/j.cell.2010.05.032;
RA   Ye J., Lenain C., Bauwens S., Rizzo A., Saint-Leger A., Poulet A.,
RA   Benarroch D., Magdinier F., Morere J., Amiard S., Verhoeyen E.,
RA   Britton S., Calsou P., Salles B., Bizard A., Nadal M., Salvati E.,
RA   Sabatier L., Wu Y., Biroccio A., Londono-Vallejo A.,
RA   Giraud-Panis M.J., Gilson E.;
RT   "TRF2 and Apollo cooperate with topoisomerase 2alpha to protect human
RT   telomeres from replicative damage.";
RL   Cell 142:230-242(2010).
RN   [16]
RP   POSSIBLE INVOLVEMENT IN HHS.
RX   PubMed=20479256; DOI=10.1073/pnas.0914918107;
RA   Touzot F., Callebaut I., Soulier J., Gaillard L., Azerrad C.,
RA   Durandy A., Fischer A., de Villartay J.P., Revy P.;
RT   "Function of Apollo (SNM1B) at telomere highlighted by a splice
RT   variant identified in a patient with Hoyeraal-Hreidarsson syndrome.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:10097-10102(2010).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 496-530 IN COMPLEX WITH
RP   TERF2, AND MUTAGENESIS OF TYR-504; LEU-506 AND PRO-508.
RX   PubMed=18202258; DOI=10.1126/science.1151804;
RA   Chen Y., Yang Y., van Overbeek M., Donigian J.R., Baciu P.,
RA   de Lange T., Lei M.;
RT   "A shared docking motif in TRF1 and TRF2 used for differential
RT   recruitment of telomeric proteins.";
RL   Science 319:1092-1096(2008).
CC   -!- FUNCTION: 5'-3' exonuclease that plays a central role in telomere
CC       maintenance and protection during S-phase. Participates in the
CC       protection of telomeres against non-homologous end-joining (NHEJ)-
CC       mediated repair, thereby ensuring that telomeres do not fuse.
CC       Plays a key role in telomeric loop (T loop) formation by being
CC       recruited by TERF2 at the leading end telomeres and by processing
CC       leading-end telomeres immediately after their replication via its
CC       exonuclease activity: generates 3' single-stranded overhang at the
CC       leading end telomeres avoiding blunt leading-end telomeres that
CC       are vulnerable to end-joining reactions and expose the telomere
CC       end in a manner that activates the DNA repair pathways. Together
CC       with TERF2, required to protect telomeres from replicative damage
CC       during replication by controlling the amount of DNA topoisomerase
CC       (TOP1, TOP2A and TOP2B) needed for telomere replication during
CC       fork passage and prevent aberrant telomere topology. Also involved
CC       in response to DNA damage: plays a role in response to DNA
CC       interstrand cross-links (ICLs) by facilitating double-strand break
CC       formation. In case of spindle stress, involved in prophase
CC       checkpoint. {ECO:0000269|PubMed:15467758,
CC       ECO:0000269|PubMed:15572677, ECO:0000269|PubMed:16730175,
CC       ECO:0000269|PubMed:16730176, ECO:0000269|PubMed:18468965,
CC       ECO:0000269|PubMed:18469862, ECO:0000269|PubMed:19197158,
CC       ECO:0000269|PubMed:19411856, ECO:0000269|PubMed:20655466}.
CC   -!- SUBUNIT: Interacts with TERF2; the interaction is direct.
CC       Interacts with MUS81, MRE11 and FANCD2. Interacts with HSPA2,
CC       HSPA8 and HSPA14. Interacts with SPAG5.
CC       {ECO:0000269|PubMed:16606622, ECO:0000269|PubMed:16730175,
CC       ECO:0000269|PubMed:16730176, ECO:0000269|PubMed:18202258,
CC       ECO:0000269|PubMed:18468965, ECO:0000269|PubMed:18469862,
CC       ECO:0000269|PubMed:18593705, ECO:0000269|PubMed:19197158,
CC       ECO:0000269|PubMed:19411856, ECO:0000269|PubMed:20655466}.
CC   -!- INTERACTION:
CC       Q15554:TERF2; NbExp=6; IntAct=EBI-3508943, EBI-706637;
CC   -!- SUBCELLULAR LOCATION: Chromosome, telomere. Nucleus. Cytoplasm,
CC       cytoskeleton, microtubule organizing center, centrosome.
CC       Note=Mainly localizes to telomeres, recruited via its interaction
CC       with TERF2. During mitosis, localizes to the centrosome.
CC   -!- DOMAIN: The TBM domain mediates interaction with TERF2.
CC   -!- PTM: Ubiquitinated, leading to its degradation. Interaction with
CC       TERF2 protects it from ubiquitination.
CC       {ECO:0000269|PubMed:18593705}.
CC   -!- DISEASE: Hoyeraal-Hreidarsson syndrome (HHS) [MIM:305000]: A
CC       clinically severe variant of dyskeratosis congenita that is
CC       characterized by multisystem involvement, early onset in utero,
CC       and often results in death in childhood. Affected individuals show
CC       intrauterine growth retardation, microcephaly, cerebellar
CC       hypoplasia, delayed development, and bone marrow failure resulting
CC       in immunodeficiency. {ECO:0000269|PubMed:20479256}. Note=The gene
CC       represented in this entry may be involved in disease pathogenesis.
CC       An aberrant splice variant of DCLRE1B, designated Apollo-Delta,
CC       has been found in a patient with Hoyeraal-Hreidarsson syndrome
CC       (PubMed:20479256). Apollo-Delta hampers the proper replication of
CC       telomeres, leading to major telomeric dysfunction and cellular
CC       senescence, but maintains its DNA interstrand cross-link repair
CC       function in the whole genome. {ECO:0000269|PubMed:20479256}.
CC   -!- MISCELLANEOUS: Was named 'Apollo' in reference to the twin brother
CC       of 'Artemis' in Greek mythology (PubMed:16730175 and
CC       PubMed:16730176). Artemis/DCLRE1C is a related nuclease.
CC   -!- SIMILARITY: Belongs to the DNA repair metallo-beta-lactamase
CC       (DRMBL) family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB14284.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/dclre1b/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK022872; BAB14284.1; ALT_INIT; mRNA.
DR   EMBL; AK024060; BAB14807.1; -; mRNA.
DR   EMBL; AY849379; AAV97812.1; -; Genomic_DNA.
DR   EMBL; AL137856; CAI19076.1; -; Genomic_DNA.
DR   EMBL; BC029687; AAH29687.1; -; mRNA.
DR   CCDS; CCDS866.1; -.
DR   RefSeq; NP_073747.1; NM_022836.3.
DR   UniGene; Hs.591412; -.
DR   PDB; 3BUA; X-ray; 2.50 A; E/F/G/H=495-530.
DR   PDB; 5AHO; X-ray; 2.16 A; A=1-335.
DR   PDBsum; 3BUA; -.
DR   PDBsum; 5AHO; -.
DR   ProteinModelPortal; Q9H816; -.
DR   SMR; Q9H816; 1-313.
DR   BioGrid; 122331; 5.
DR   DIP; DIP-42669N; -.
DR   IntAct; Q9H816; 3.
DR   MINT; MINT-3372972; -.
DR   STRING; 9606.ENSP00000358576; -.
DR   PhosphoSite; Q9H816; -.
DR   BioMuta; DCLRE1B; -.
DR   DMDM; 73620756; -.
DR   PaxDb; Q9H816; -.
DR   PRIDE; Q9H816; -.
DR   DNASU; 64858; -.
DR   Ensembl; ENST00000369563; ENSP00000358576; ENSG00000118655.
DR   GeneID; 64858; -.
DR   KEGG; hsa:64858; -.
DR   UCSC; uc001eeg.3; human.
DR   CTD; 64858; -.
DR   GeneCards; GC01P114447; -.
DR   HGNC; HGNC:17641; DCLRE1B.
DR   MIM; 305000; phenotype.
DR   MIM; 609683; gene.
DR   neXtProt; NX_Q9H816; -.
DR   PharmGKB; PA27175; -.
DR   eggNOG; COG1236; -.
DR   GeneTree; ENSGT00530000063183; -.
DR   HOGENOM; HOG000043118; -.
DR   HOVERGEN; HBG081420; -.
DR   KO; K15341; -.
DR   OMA; PCQVVPI; -.
DR   OrthoDB; EOG71VSSC; -.
DR   PhylomeDB; Q9H816; -.
DR   TreeFam; TF329572; -.
DR   EvolutionaryTrace; Q9H816; -.
DR   GeneWiki; DCLRE1B; -.
DR   GenomeRNAi; 64858; -.
DR   NextBio; 67007; -.
DR   PRO; PR:Q9H816; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; Q9H816; -.
DR   CleanEx; HS_DCLRE1B; -.
DR   Genevisible; Q9H816; HS.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0000781; C:chromosome, telomeric region; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0008409; F:5'-3' exonuclease activity; IDA:UniProtKB.
DR   GO; GO:0000075; P:cell cycle checkpoint; IMP:UniProtKB.
DR   GO; GO:0006281; P:DNA repair; IEA:UniProtKB-KW.
DR   GO; GO:0090305; P:nucleic acid phosphodiester bond hydrolysis; IDA:GOC.
DR   GO; GO:0031848; P:protection from non-homologous end joining at telomere; IMP:UniProtKB.
DR   GO; GO:0000723; P:telomere maintenance; IMP:UniProtKB.
DR   GO; GO:0031860; P:telomeric 3' overhang formation; ISS:UniProtKB.
DR   GO; GO:0031627; P:telomeric loop formation; ISS:UniProtKB.
DR   Gene3D; 3.60.15.10; -; 1.
DR   InterPro; IPR001279; Beta-lactamas-like.
DR   InterPro; IPR011084; DRMBL.
DR   Pfam; PF07522; DRMBL; 1.
DR   SMART; SM00849; Lactamase_B; 1.
DR   SUPFAM; SSF56281; SSF56281; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Chromosome; Complete proteome; Cytoplasm; Cytoskeleton;
KW   DNA damage; DNA repair; Dyskeratosis congenita; Exonuclease;
KW   Hydrolase; Nuclease; Nucleus; Polymorphism; Reference proteome;
KW   Telomere; Ubl conjugation.
FT   CHAIN         1    532       5' exonuclease Apollo.
FT                                /FTId=PRO_0000209119.
FT   MOTIF       496    511       TBM.
FT   VARIANT      46     46       R -> L (in dbSNP:rs28381069).
FT                                {ECO:0000269|Ref.2}.
FT                                /FTId=VAR_023292.
FT   VARIANT      61     61       H -> Y (in dbSNP:rs11552449).
FT                                {ECO:0000269|Ref.2}.
FT                                /FTId=VAR_023293.
FT   VARIANT     462    462       D -> N (in dbSNP:rs28381079).
FT                                {ECO:0000269|Ref.2}.
FT                                /FTId=VAR_023294.
FT   VARIANT     510    510       N -> Y (in dbSNP:rs35397235).
FT                                /FTId=VAR_048891.
FT   MUTAGEN      14     14       D->N: In Apm3; abolishes exonuclease
FT                                activity and function on telomere
FT                                maintenance. Impairs interaction with
FT                                SPAG5. {ECO:0000269|PubMed:19197158,
FT                                ECO:0000269|PubMed:20655466}.
FT   MUTAGEN      33     33       H->A: In Apm1; abolishes exonuclease
FT                                activity and function on telomere
FT                                maintenance; when associated with N-35.
FT                                {ECO:0000269|PubMed:20655466}.
FT   MUTAGEN      35     35       D->N: In Apm2; abolishes exonuclease
FT                                activity and function on telomere
FT                                maintenance. In Apm1; abolishes
FT                                exonuclease activity and function on
FT                                telomere maintenance; when associated
FT                                with A-33. {ECO:0000269|PubMed:20655466}.
FT   MUTAGEN     276    276       H->A: Slightly affects interaction with
FT                                SPAG5. {ECO:0000269|PubMed:19197158}.
FT   MUTAGEN     504    504       Y->A: Abolishes interaction with TERF2.
FT                                {ECO:0000269|PubMed:18202258}.
FT   MUTAGEN     506    506       L->A: Abolishes interaction with TERF2.
FT                                {ECO:0000269|PubMed:18202258}.
FT   MUTAGEN     508    508       P->A: Abolishes interaction with TERF2.
FT                                {ECO:0000269|PubMed:18202258}.
FT   CONFLICT    237    237       I -> T (in Ref. 1; BAB14284).
FT                                {ECO:0000305}.
FT   STRAND        4      6       {ECO:0000244|PDB:5AHO}.
FT   TURN          7     10       {ECO:0000244|PDB:5AHO}.
FT   STRAND       11     14       {ECO:0000244|PDB:5AHO}.
FT   HELIX        18     21       {ECO:0000244|PDB:5AHO}.
FT   STRAND       26     28       {ECO:0000244|PDB:5AHO}.
FT   HELIX        34     36       {ECO:0000244|PDB:5AHO}.
FT   STRAND       48     50       {ECO:0000244|PDB:5AHO}.
FT   HELIX        52     61       {ECO:0000244|PDB:5AHO}.
FT   TURN         66     68       {ECO:0000244|PDB:5AHO}.
FT   STRAND       69     71       {ECO:0000244|PDB:5AHO}.
FT   STRAND       76     86       {ECO:0000244|PDB:5AHO}.
FT   STRAND       89     96       {ECO:0000244|PDB:5AHO}.
FT   STRAND       98    100       {ECO:0000244|PDB:5AHO}.
FT   STRAND      104    110       {ECO:0000244|PDB:5AHO}.
FT   STRAND      113    117       {ECO:0000244|PDB:5AHO}.
FT   HELIX       125    129       {ECO:0000244|PDB:5AHO}.
FT   HELIX       131    133       {ECO:0000244|PDB:5AHO}.
FT   STRAND      140    144       {ECO:0000244|PDB:5AHO}.
FT   HELIX       158    170       {ECO:0000244|PDB:5AHO}.
FT   STRAND      175    181       {ECO:0000244|PDB:5AHO}.
FT   STRAND      183    185       {ECO:0000244|PDB:5AHO}.
FT   HELIX       187    196       {ECO:0000244|PDB:5AHO}.
FT   HELIX       205    214       {ECO:0000244|PDB:5AHO}.
FT   STRAND      220    222       {ECO:0000244|PDB:5AHO}.
FT   HELIX       224    226       {ECO:0000244|PDB:5AHO}.
FT   STRAND      228    233       {ECO:0000244|PDB:5AHO}.
FT   HELIX       234    236       {ECO:0000244|PDB:5AHO}.
FT   HELIX       239    246       {ECO:0000244|PDB:5AHO}.
FT   STRAND      251    256       {ECO:0000244|PDB:5AHO}.
FT   STRAND      268    271       {ECO:0000244|PDB:5AHO}.
FT   HELIX       279    289       {ECO:0000244|PDB:5AHO}.
FT   STRAND      294    298       {ECO:0000244|PDB:5AHO}.
FT   HELIX       307    309       {ECO:0000244|PDB:5AHO}.
FT   HELIX       500    503       {ECO:0000244|PDB:3BUA}.
SQ   SEQUENCE   532 AA;  60002 MW;  601A800CCD43CFDA CRC64;
     MNGVLIPHTP IAVDFWSLRR AGTARLFFLS HMHSDHTVGL SSTWARPLYC SPITAHLLHR
     HLQVSKQWIQ ALEVGESHVL PLDEIGQETM TVTLLDANHC PGSVMFLFEG YFGTILYTGD
     FRYTPSMLKE PALTLGKQIH TLYLDNTNCN PALVLPSRQE AAHQIVQLIR KHPQHNIKIG
     LYSLGKESLL EQLALEFQTW VVLSPRRLEL VQLLGLADVF TVEEKAGRIH AVDHMEICHS
     NMLRWNQTHP TIAILPTSRK IHSSHPDIHV IPYSDHSSYS ELRAFVAALK PCQVVPIVSR
     RPCGGFQDSL SPRISVPLIP DSVQQYMSSS SRKPSLLWLL ERRLKRPRTQ GVVFESPEES
     ADQSQADRDS KKAKKEKLSP WPADLEKQPS HHPLRIKKQL FPDLYSKEWN KAVPFCESQK
     RVTMLTAPLG FSVHLRSTDE EFISQKTREE IGLGSPLVPM GDDDGGPEAT GNQSAWMGHG
     SPLSHSSKGT PLLATEFRGL ALKYLLTPVN FFQAGYSSRR FDQQVEKYHK PC
//
